Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China flag China · Delayed Price · Currency is CNY
40.26
+2.76 (7.36%)
Feb 13, 2026, 3:00 PM CST

Hangzhou Biotest Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5,8913,4523,2294,9287,456-
Market Cap Growth
65.87%6.92%-34.48%-33.91%--
Enterprise Value
4,3691,8451,3702,7745,736-
Last Close Price
40.2622.7320.2128.7141.65-
PE Ratio
61.6220.3630.296.378.94-
PS Ratio
12.316.177.302.594.10-
PB Ratio
2.521.431.331.923.54-
P/TBV Ratio
2.851.621.462.103.57-
P/FCF Ratio
418.04-43.089.4010.53-
P/OCF Ratio
62.7526.8024.587.018.21-
EV/Sales Ratio
9.133.303.101.463.16-
EV/EBITDA Ratio
72.0813.7747.443.595.92-
EV/EBIT Ratio
107.7416.36325.743.695.97-
EV/FCF Ratio
310.05-18.285.298.10-
Debt / Equity Ratio
000.000.000.010.03
Debt / EBITDA Ratio
0.000.000.090.010.010.02
Debt / FCF Ratio
0.01-0.040.020.020.03
Net Debt / Equity Ratio
-0.65-0.68-0.79-0.79-0.81-0.56
Net Debt / EBITDA Ratio
-25.71-12.32-66.28-2.63-1.77-0.47
Net Debt / FCF Ratio
-108.1114.20-25.54-3.88-2.42-0.64
Asset Turnover
0.190.220.170.731.192.05
Inventory Turnover
3.393.322.306.796.033.77
Quick Ratio
12.919.8113.2712.165.931.93
Current Ratio
13.6610.5113.9713.076.402.46
Return on Equity (ROE)
4.26%6.90%4.23%33.13%65.52%152.90%
Return on Assets (ROA)
1.01%2.72%0.10%18.15%39.19%77.90%
Return on Invested Capital (ROIC)
4.37%15.22%0.74%140.06%283.49%263.93%
Return on Capital Employed (ROCE)
1.70%4.70%0.20%29.20%45.50%118.70%
Earnings Yield
1.74%4.91%3.30%15.70%11.18%-
FCF Yield
0.24%-3.37%2.32%10.64%9.50%-
Dividend Yield
2.66%4.71%2.83%5.47%5.15%-
Payout Ratio
157.54%49.34%220.13%41.37%2.51%23.07%
Buyback Yield / Dilution
-6.66%1.23%0.10%-23.14%-8.33%0.01%
Total Shareholder Return
-3.80%5.95%2.93%-17.67%-3.18%0.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.